GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedReleaf Corp (OTCPK:MEDFF) » Definitions » Current Deferred Revenue

MedReleaf (MedReleaf) Current Deferred Revenue : $0.00 Mil (As of Mar. 2018)


View and export this data going back to 2017. Start your Free Trial

What is MedReleaf Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

MedReleaf's current deferred revenue for the quarter that ended in Mar. 2018 was $0.00 Mil.

MedReleaf Current Deferred Revenue Historical Data

The historical data trend for MedReleaf's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedReleaf Current Deferred Revenue Chart

MedReleaf Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Current Deferred Revenue
- - - - -

MedReleaf Quarterly Data
Mar14 Mar15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MedReleaf Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of MedReleaf's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MedReleaf (MedReleaf) Business Description

Traded in Other Exchanges
N/A
Address
MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence.